Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07739745

Development Of An Endometrial Cancer Educational Tool

The goal of this study is to develop an online educational tool that we can make widely available to broader patient community.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

UT MD Anderson

Houston, Texas, 77030, United States

Location contact

Larissa Meyer, MD, MPH

CONTACT

[email protected]

713-745-0973

Larissa Meyer, MD, MPH

PRINCIPAL_INVESTIGATOR

About this study

Primary Objectives:

  • To develop an EC educational tool for systemic therapy of endometrial cancer.
  • To explore:
  • Acceptability of incorporating the EC educational tool into routine clinical care through a pilot study with EC patients
  • Feasibility, acceptability and the appropriateness of incorporating the EC educational tool into routine clinical care through a pilot study with health care providers of EC patients
  • To estimate the effectiveness of the EC educational tool with EC patients through a pilot study of EC patients and their health care providers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients:

Study Objective 1 (Part A-C see Figure 2)

  • Women who have been diagnosed with endometrial cancer
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written informed consent

Study Objectives 2 and 3 (Pilot Study)

  • Women who have been diagnosed with endometrial cancer who are or will be receiving systemic treatment
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written informed consent.

Physicians:

Study Objective 1 (Qualitative Interviews)

  • Gynecologic oncologists or medical oncologists who practice at MDA or outside institutions
  • Must be able to speak and read English
  • Must provide written informed consent

Healthcare Providers:

Study Objectives 2 and 3 (Pilot Study)

  • Healthcare Providers (including but not limited to gynecologic oncologists and APPs) who practice at MDA, the HALs or LBJ Hospital who provide care to women diagnosed with endometrial cancer
  • Must be able to speak and read English
  • Must provide written informed consent

Exclusion criteria

None

Treatment and study plan

Interactive Educational Website

Other

Participants will utilize website to access educational content, knowledge measure, values survey, and cognitive and usability testing

Primary outcomes

  1. Safety and Adverse Events (AEs)

    Time frame: Through study completion; an average of 1 year

    Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Study contacts

Contact information is provided by the study sponsor or research team.

Larissa Meyer, MD, MPH

CONTACT

[email protected]

(713) 745-0973

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2027
Primary completion
2030
Study completion
2032
First posted
Jul 31, 2026
Registry last updated
Jul 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.